NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · IEX Real-Time Price · USD
1.240
+0.160 (14.81%)
At close: Jul 2, 2024, 4:00 PM
1.250
+0.010 (0.81%)
After-hours: Jul 2, 2024, 7:58 PM EDT
NeuroSense Therapeutics Market Cap
NeuroSense Therapeutics has a market cap or net worth of $22.37 million as of July 2, 2024. Its market cap has increased by 24.25% in one year.
Market Cap
22.37M
Enterprise Value
19.80M
1-Year Change
24.25%
Ranking
Category
Stock Price
$1.24
Market Cap Chart
Since the IPO on December 9, 2021, NeuroSense Therapeutics's market cap has decreased from $64.61M to $22.37M, a decrease of -65.38%. That is a compound annual growth rate of -33.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 19.10M | 94.90% |
| Dec 29, 2023 | 9.80M | -29.50% |
| Dec 30, 2022 | 13.90M | -47.55% |
| Dec 31, 2021 | 26.50M | -58.98% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AIM ImmunoTech | 21.29M |
| Singular Genomics Systems | 20.87M |
| BriaCell Therapeutics | 20.84M |
| NanoViricides | 20.32M |
| American Shared Hospital Services | 20.22M |
| Renalytix | 20.00M |
| Kala Pharmaceuticals | 19.97M |
| ATI Physical Therapy | 19.64M |